position: EnglishChannel > Visual Stories > Article

Beijing positively reacts to the new epidemic situation

Source: Science and Technology Daily| 2020-06-19 17:31:48| Author: Science and Technology Daily

Since June 11, when the new confirmed domestically transmitted COVID-19 cases in Beijing were continually reported, Beijing has gradually expanded its nucleic acid detection for the novel coronavirus. 

In recent days, based on the principle of “those who should be tested will be tested, and those who wish to be tested will be tested”, Beijing has started novel coronavirus nucleic acid test for its citizens. According to reports, 193 sampling sites have been set up in Beijing. 

  

The staff in protection clothing offer help to people who came to take the nucleic acid test (NAT) in the test center at Guang'an Stadium in Xicheng District, Beijing, June 16,2020. (Photo/Zhou Weihai)

Residents undergo the nucleic acid test at Guang'an stadium in Beijing's Xicheng district,June 16,2020. (Photo/Zhou Weihai) 

An epidemic prevention team conducts disinfection at the Beijing Railway Station, June 18,2020 (Photo/Zhou Weihai)

Epidemic prevention workers disinfect every seats carefully in the Beijing Railway Station, June 18,2020 (Photo/Zhou Weihai)

  

People buy fruits normally in the market after new Covid-19 cases reported in Beijing,June 18,2020 (Photo/Zhou Weihai)

  

Editor:余昊原

Top News

  • By the end of July, China had increased its daily nucleic acid testing (NAT) capacity to 4.84 million. A total of 4,946 medical institutions, manned by more than 38,000 technicians, are now capable of conducting the test to identify the presence of COVID-19.

Researchers discover mechanism that makes COVID-19 more severe in diabetics

Brazilian researchers have discovered one of the causes of severe COVID-19 in diabetic patients. Laboratory experiments showed that the higher level of blood sugar in these patients is captured by monocytes, a type of defense cell, and serves as a source of additional energy for the coronavirus to replicate more than in a healthy organism. In response to the increased viral load, the monocytes release large amounts of pro-inflammatory cytokines with several effects including lung cell death.

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

Copyright © Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com